BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37882750)

  • 1. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
    Schäfer RA; Guo Q; Yang R
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nextNEOpi: a comprehensive pipeline for computational neoantigen prediction.
    Rieder D; Fotakis G; Ausserhofer M; René G; Paster W; Trajanoski Z; Finotello F
    Bioinformatics; 2022 Jan; 38(4):1131-1132. PubMed ID: 34788790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction.
    Kodysh J; Rubinsteyn A
    Methods Mol Biol; 2020; 2120():147-160. PubMed ID: 32124317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
    Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction.
    Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
    Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
    Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LENS: Landscape of Effective Neoantigens Software.
    Vensko SP; Olsen K; Bortone D; Smith CC; Chai S; Beckabir W; Fini M; Jadi O; Rubinsteyn A; Vincent BG
    Bioinformatics; 2023 May; 39(6):. PubMed ID: 37184881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
    Zhang J; Mardis ER; Maher CA
    Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoantigen identification: Technological advances and challenges.
    Pu T; Peddle A; Zhu J; Tejpar S; Verbandt S
    Methods Cell Biol; 2024; 183():265-302. PubMed ID: 38548414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline.
    Schenck RO; Lakatos E; Gatenbee C; Graham TA; Anderson ARA
    BMC Bioinformatics; 2019 May; 20(1):264. PubMed ID: 31117948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices for bioinformatic characterization of neoantigens for clinical utility.
    Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
    Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo.
    Wang TY; Yang R
    STAR Protoc; 2021 Sep; 2(3):100788. PubMed ID: 34522901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
    Shi Y; Jing B; Xi R
    Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
    Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
    Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
    Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. neoANT-HILL: an integrated tool for identification of potential neoantigens.
    Coelho ACMF; Fonseca AL; Martins DL; Lins PBR; da Cunha LM; de Souza SJ
    BMC Med Genomics; 2020 Feb; 13(1):30. PubMed ID: 32087727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FusionNeoAntigen: a resource of fusion gene-specific neoantigens.
    Kumar H; Luo R; Wen J; Yang C; Zhou X; Kim P
    Nucleic Acids Res; 2024 Jan; 52(D1):D1276-D1288. PubMed ID: 37870454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NeoFuse: predicting fusion neoantigens from RNA sequencing data.
    Fotakis G; Rieder D; Haider M; Trajanoski Z; Finotello F
    Bioinformatics; 2020 Apr; 36(7):2260-2261. PubMed ID: 31755900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Prediction of Tumor Neoantigens with TIminer.
    Kirchmair A; Finotello F
    Methods Mol Biol; 2020; 2120():129-145. PubMed ID: 32124316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.